Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5643568 | Sleep Medicine | 2017 | 15 Pages |
Abstract
CPAP-treated patients present more comorbidities before and after diagnosis compared with non-treated/non-compliant patients, which explains the higher mortality in this group. CPAP treatment is associated with lower mortality rates in middle-aged and elderly (aged 60+ years) males, but only after adjustment for multiple comorbidities. No effect of CPAP treatment on all-cause mortality in female OSA patients was found. Males with OSA, older than 40 years, with comorbidities and a low educational level presented a particularly high mortality risk.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Poul Jennum, Philip Tønnesen, Rikke Ibsen, Jakob Kjellberg,